<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>News Topic - Eli Lilly</title>
<link>http://www.news-spider.com/topics/e/Eli_Lilly/index.html</link>
<atom:link href="http://www.news-spider.com/topics/Eli_Lilly/index.rss" rel="self" type="application/rss+xml" />
<description>Latest news about Eli Lilly from news-spider.com. News from more than 2,000 sources, updated continuously.</description>
<language>en-us</language>
<copyright>Copyright (c) 2008 news-spider.com. All rights reserved.</copyright>
<pubDate>Thu, 4 Dec 2008 05:05:14 GMT</pubDate>
<item>
<title>It's Wait Until Next Year for These Drugmakers</title>
<link>http://www.news-spider.com/comments/1228169455</link>
<description>Drugs from AstraZeneca and Eli Lilly face delays because of the FDA.</description>
<guid isPermaLink="true">http://www.news-spider.com/comments/1228169455</guid>
<pubDate>Mon, 1 Dec 2008 20:04:28 GMT</pubDate>
</item>
<item>
<title>Lilly pulls form for OK of Cymbalta</title>
<link>http://www.news-spider.com/comments/1227956407</link>
<description>INDIANAPOLIS -- Drugmaker Eli Lilly and Co. withdrew an application to have its antidepressant Cymbalta approved as a treatment for chronic pain, but the company said Friday that it will apply again i ...</description>
<guid isPermaLink="true">http://www.news-spider.com/comments/1227956407</guid>
<pubDate>Sat, 29 Nov 2008 08:00:00 GMT</pubDate>
</item>
<item>
<title>Drug Company Withdraws Application</title>
<link>http://www.news-spider.com/comments/1227925396</link>
<description>Eli Lilly withdrew its application for approval of the antidepressant Cymbalta as a treatment for chronic pain, after regulators questioned whether the drug was shown to work for that purpose. </description>
<guid isPermaLink="true">http://www.news-spider.com/comments/1227925396</guid>
<pubDate>Sat, 29 Nov 2008 01:58:41 GMT</pubDate>
</item>
<item>
<title>Lilly pulls FDA application for Cymbalta for pain</title>
<link>http://www.news-spider.com/comments/1227896406</link>
<description>Reuters - Eli Lilly and Co said on Friday it withdrew an application to market its anti-depressant Cymbalta for the management of chronic pain because U.S. health regulators raised questions about the ...</description>
<guid isPermaLink="true">http://www.news-spider.com/comments/1227896406</guid>
<pubDate>Fri, 28 Nov 2008 17:27:27 GMT</pubDate>
</item>
<item>
<title>Lilly withdraws Cymbalta chronic pain application</title>
<link>http://www.news-spider.com/comments/1227913359</link>
<description>Drugmaker Eli Lilly and Co. has withdrawn an application to have its anti-depressant Cymbalta approved as a treatment for chronic pain.</description>
<guid isPermaLink="true">http://www.news-spider.com/comments/1227913359</guid>
<pubDate>Fri, 28 Nov 2008 15:19:51 GMT</pubDate>
</item>
<item>
<title>Movers: Eli Lilly, STMicro, Panasonic, Watson Pharma</title>
<link>http://www.news-spider.com/comments/1227891540</link>
<description>Read full story for latest details.</description>
<guid isPermaLink="true">http://www.news-spider.com/comments/1227891540</guid>
<pubDate>Fri, 28 Nov 2008 13:58:00 GMT</pubDate>
</item>
<item>
<title>Eli Lilly delays FDA new-drug application for Cymbalta</title>
<link>http://www.news-spider.com/comments/1227885023</link>
<description>NEW YORK (MarketWatch) -- Eli Lilly &amp;#x26; Co. said Friday it has withdrawn its new-drug application to the U.S. Food &amp;#x26; Drug Administration for its chronic-pain medication Cymbalta. The Indianapolis pharma ...</description>
<guid isPermaLink="true">http://www.news-spider.com/comments/1227885023</guid>
<pubDate>Fri, 28 Nov 2008 13:25:08 GMT</pubDate>
</item>
<item>
<title>TorreyPines Therapeutics Enters into Agreement to Reduce Royalty Rates and Delay Clinical Milestone Payments Due to Eli Lilly for NGX426 and Tezampane</title>
<link>http://www.news-spider.com/comments/1227627380</link>
<description>Read full story for latest details.</description>
<guid isPermaLink="true">http://www.news-spider.com/comments/1227627380</guid>
<pubDate>Tue, 25 Nov 2008 14:37:00 GMT</pubDate>
</item>
<item>
<title>Fitch cuts Eli Lilly to 'A+' on ImClone acquisition</title>
<link>http://www.news-spider.com/comments/1227560880</link>
<description>SAN FRANCISCO (MarketWatch) -- Fitch Ratings on Monday lowered Eli Lilly and Co.'s issuer default rating to A+ from AA and its short-term IDR to F1 from F1+. The downgrade is due to the the incrementa ...</description>
<guid isPermaLink="true">http://www.news-spider.com/comments/1227560880</guid>
<pubDate>Mon, 24 Nov 2008 19:17:36 GMT</pubDate>
</item>
<item>
<title>Lilly completes ImClone deal</title>
<link>http://www.news-spider.com/comments/1227546566</link>
<description>NEW YORK (MarketWatch) -- Eli Lilly and Co. said Monday that it has completed its acquisition of ImClone Systems, which is now a wholly-owned subsidiary of Lilly. John Johnson will remain ImClone's ch ...</description>
<guid isPermaLink="true">http://www.news-spider.com/comments/1227546566</guid>
<pubDate>Mon, 24 Nov 2008 14:41:40 GMT</pubDate>
</item>
</channel>
</rss>